文献速递肥胖与代谢综合征

孕期母体皮质醇与婴儿脂肪含量:一项前瞻性研究

Maternal Cortisol During Pregnancy and Infant Adiposity: A Prospective Investigation.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

该前瞻性研究纳入67对母婴,在早、中、晚孕期连续4天各采集5份唾液评估母体累积皮质醇,并在新生儿约25天及约6个月时用双能X线吸收法评估婴儿体成分。调整关键协变量后,晚孕早期(约30周)母体皮质醇较高与婴儿1至6个月体脂百分比变化较大显著相关(偏r=0.379,P=0.007),解释约14%的变异。

要点

  • 晚孕早期母体皮质醇较高与婴儿1至6个月体脂百分比增加显著相关(偏r=0.379,P=0.007)。
  • 该关联独立于早孕和中孕皮质醇浓度,解释约14%的童年肥胖风险指标变异。
  • 作者认为这提示母体皮质醇对婴儿早期产后脂肪增加存在孕周特异性效应。

核心结论

  • 作者认为本研究提示母体皮质醇对婴儿早期产后脂肪增加存在孕周特异性效应,并为糖皮质激素在人类胎儿编程中影响童年肥胖风险提供了证据。

研究设计与样本

  • 前瞻性研究,在加利福尼亚南部大学附属产科诊所于早孕期招募67对母婴,从早孕期随访至出生后6个月。
  • 在早孕(约13周)、中孕(约24周)、晚孕(约30周)各连续4天每天采集5份唾液,共60份唾液/受试者,评估母体累积皮质醇产量。
  • 在新生儿约25天日龄及约6个月龄时用双能X线吸收法连续评估婴儿体成分。

主要发现

  • 调整关键产前、出生及产后协变量后,晚孕早期(以早孕和中孕皮质醇浓度为条件)母体皮质醇较高与婴儿1至6个月龄体脂百分比变化较大显著相关(偏r=0.379,P=0.007)。
  • 该指标解释约14%的童年肥胖风险指标变异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Glucocorticoids play a key role during intrauterine development in cellular growth and differentiation. Evidence suggests that exposure to inappropriate concentrations of glucocorticoids during sensitive developmental periods may produce alterations in physiological systems that impact obesity risk. OBJECTIVE: To elucidate the magnitude and stage-of-gestation-specific association of maternal cortisol concentrations during pregnancy with infant adiposity. DESIGN, PARTICIPANTS, AND SETTING: Sixty-seven mother-child dyads recruited in early pregnancy at university-based obstetric clinics in Southern California were followed with serial assessments from early gestation through birth until 6 months postnatal age. Maternal cumulative cortisol production was assessed over each of 4 consecutive days in early (≅13 weeks), mid (≅24 weeks), and late pregnancy (≅30 weeks) (5 saliva samples/d × 4 days × 3 trimesters = 60 saliva samples/subject). Infant body composition was serially assessed in newborns (at ∼25 days postnatal age) and at ∼6 months age with dual-energy X-ray absorptiometry imaging. RESULTS: After adjusting for key prenatal, birth, and postnatal covariates, higher maternal cortisol during the early third trimester (conditioned on prior early and midgestation cortisol concentrations) was significantly associated with a greater change in infant percent body fat from 1 to 6 months of age [partial r (adjusted for covariates) = 0.379, P = 0.007], accounting for ∼14% of the variance in this measure of childhood obesity risk. CONCLUSION: The present findings suggest a stage-of-gestation-specific effect of maternal cortisol on infant adiposity gain in early postnatal life and provide evidence in humans to support the role of glucocorticoids in fetal programming of childhood obesity risk.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Entringer S, Buss C, Rasmussen JM, et al. Maternal Cortisol During Pregnancy and Infant Adiposity: A Prospective Investigation. J Clin Endocrinol Metab. 2017. PMID: 28009530. doi:10.1210/jc.2016-3025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。